SCHEMBL21148239

SCHEMBL21148239

c1ccc2c(c1)ccc1cc(-c3nc(-c4ccc(-c5cccc6oc7ccccc7c56)cc4)nc(-c4ccc(-c5cccc6oc7ccccc7c56)cc4)n3)ccc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 4/20 0.42
TDP1 Q9NUW8 3/20 0.42
BACE1 P56817 1/20 0.39
HSD17B10 Q99714 8/20 0.38
ALDH1A1 P00352 7/20 0.38
HPGD P15428 6/20 0.38
KDM4E B2RXH2 6/20 0.38
MAPT P10636 5/20 0.38
TSHR P16473 4/20 0.38
MAPK1 P28482 3/20 0.38
ATM Q13315 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
TP53 P04637 1/20 0.38
NFKB1 P19838 1/20 0.38
NFKB2 Q00653 1/20 0.38
RELA Q04206 1/20 0.38
CASP1 P29466 2/20 0.37
HIF1A Q16665 2/20 0.37
CYP1A2 P05177 2/20 0.37
ERBB2 P04626 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23820408 0.97 MAPT (0.42) L3MBTL1TDP1BACE1HSD17B10ALDH1A1
SCHEMBL25503827 0.96 TDP1 (0.43) L3MBTL1TDP1BACE1HSD17B10ALDH1A1
SCHEMBL24930807 0.96 MAPT (0.41) L3MBTL1TDP1BACE1HSD17B10ALDH1A1
SCHEMBL25502083 0.95 L3MBTL1 (0.39) L3MBTL1TDP1BACE1HSD17B10ALDH1A1
SCHEMBL23822643 0.95 L3MBTL1 (0.39) L3MBTL1TDP1BACE1HSD17B10ALDH1A1
SCHEMBL26048025 0.94 L3MBTL1 (0.40) L3MBTL1TDP1BACE1HSD17B10ALDH1A1
SCHEMBL23820381 0.94 MAPT (0.41) L3MBTL1TDP1BACE1HSD17B10ALDH1A1
SCHEMBL23822740 0.94 ALDH1A1 (0.41) L3MBTL1TDP1HSD17B10ALDH1A1HPGD
SCHEMBL21148456 0.93 L3MBTL1 (0.41) L3MBTL1TDP1BACE1HSD17B10ALDH1A1
SCHEMBL23822644 0.93 L3MBTL1 (0.41) L3MBTL1TDP1BACE1HSD17B10ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230329097-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE SAMSUNG SDI CO LTD (KR) 2023-10-12 US disclosed
US-20230329097-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE SAMSUNG SDI CO LTD (KR) 2023-10-12 US disclosed
US-20190214573-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2019-07-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190214573-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE OR10J3, OCIAD2, OCIAD1 L3MBTL1 4601/4885TDP1 3810/4885BACE1 3161/4885
US-20230329097-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE OR10J3, OCIAD2, OCIAD1 L3MBTL1 4601/4885TDP1 3810/4885BACE1 3161/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.